Strassenburg Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.10 Cr
as on 28-07-2024
- Paid Up Capital ₹ 1.60 Cr
as on 28-07-2024
- Company Age 39 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.00 Cr
as on 28-07-2024
- Revenue 11.31%
(FY 2020)
- Profit 16.27%
(FY 2020)
- Ebitda 3.50%
(FY 2020)
- Net Worth 14.83%
(FY 2020)
- Total Assets 13.47%
(FY 2020)
About Strassenburg Pharmaceuticals
The Corporate was formerly known as Strassen Burg Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.10 Cr and a paid-up capital of Rs 1.60 Cr.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anupama Chowdhury, Jita Roychowdhury, Bijoyinee Roychowdhury, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24233WB1985PTC039196
- Company No.
039196
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Jul 1985
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Strassenburg Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deep Roychowdhury  | Managing Director | 01-Jun-2003 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anupama Chowdhury | Director | 25-Apr-2008 | Current |
| Jita Roychowdhury | Director | 25-Apr-2008 | Current |
| Bijoyinee Roychowdhury | Director | 25-Apr-2008 | Current |
| Rupnath Roychowdhury | Director | 07-Aug-1995 | Current |
| Meghnath Chowdhury | Director | 01-Oct-1998 | Current |
Financial Performance and Corporate Structure Insights of Strassenburg Pharmaceuticals.
Strassenburg Pharmaceuticals Ltd., for the financial year ended 2020, experienced significant growth in revenue, with a 11.31% increase. The company also saw a substantial improvement in profitability, with a 16.27% increase in profit. The company's net worth Soared by an impressive increase of 14.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Strassenburg Pharmaceuticals?
In 2020, Strassenburg Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cans & Closures Private Limited
Active 53 years 7 monthsAnupama Chowdhury, Jita Roychowdhury and 4 more are mutual person
Atithya Dealcom Private Limited
Active 17 years 7 monthsRupnath Roychowdhury, Meghnath Chowdhury and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Allahabad Bank Creation Date: 19 Apr 2000 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Strassenburg Pharmaceuticals?
Strassenburg Pharmaceuticals has a workforce of 617 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Strassenburg Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Strassenburg Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
